It's still too early in 2020 to proclaim the cannabis equity and exchanged traded funds rebound legitimate, but at least a comeback is materializing. The still maturing resurgence is important following a year in which essentially all of the U.S.-listed cannabis funds were among 2019's worst-performing ETFs.
What To Know
The AdvisorShares Pure Cannabis ETF (NYSE: YOLO), the first actively managed cannabis ETF in the U.S., is one of the funds in this category that's on the mend, sort of, to start 2020. YOLO's 5.26% gain this month is much needed after the fund was pummeled following its debut last April.
YOLO is one of the only cannabis ETFs with exposure to U.S.-based multi-state operators (MSOs), a trait that could stoke the fund's recent ascent.
“YOLO invests in exposure to United States multi-state operations (MSO’s) including those operating in Illinois: Green Thumb Industries (OTC: GTBIF), Cresco Labs (OTC:CRLSF), and Curaleaf (OTC: CURLF),” portfolio manager Dan Ahrens wrote in a recent note.
YOLO obtains its MSO exposure via swaps.
Benzinga's Cannabis Capital Conference returns to Miami Feb. 24-25 with North America's largest B2B cannabis gathering, bringing together capital, cannabis executives, thought leaders and more!
Why It's Important
Another marquee holding in YOLO is Innovative Industrial Properties, Inc (NYSE: IIPR), the original cannabis real estate investment trust.
“It’s another cannabis-related company doing important business in Illinois. As a U.S.-listed REIT, it cannot be held in an index-based cannabis equity ETF,” said Ahrens. “We hold it because, as an actively managed ETF, we can. I’ve seen lots of articles touting Illinois’s successful cannabis sales, but also inaccurately depicting cannabis stocks and cannabis funds as basically all the being the same. They are not!”
Another benefit offered by YOLO is that the fund is significantly underweight Canadian cannabis stocks, including some of the laggards that dominate passively managed rivals. In fact, Tilray (NASDAQ: TLRY) and Aurora Cannabis (NYSE: ACB) combine for less than 2.5% of YOLO's roster.
“We greatly underweight Canadian companies Tilray, HEXO and Aurora, but still maintain small positions. They were terrible again in December – down double digits,” said Ahrens. “Like I’ve stated each month previously, since its launch on April 18 of this year, YOLO still has yet to experience any out-flow of shares (ETF redemption units). It makes me confident of our future upside. I think investors believe in YOLO’s active investment management and higher U.S. exposure not normally found in competitor funds in the cannabis space.”